1. EP4 receptor agonist L-902688 augments cytotoxic activities of ibrutinib, idelalisib, and venetoclax against chronic lymphocytic leukemia cellsSanja Nabergoj, Tijana Markovič, Damjan Avsec, Martina Gobec, Helena Podgornik, Žiga Jakopin, Irena Mlinarič-Raščan, 2021, izvirni znanstveni članek Ključne besede: chronic lymphocytic leukemia, L-902688, NF-κB inhibition, prostaglandin E4, receptor, synergistic cytotoxic activity, prostaglandin E4 receptor Celotno besedilo (datoteka, 3,50 MB) Gradivo ima več datotek! Več... |
|
|
|
|
|
|
|
9. Targeting autophagy triggers apoptosis and complements the action of venetoclax in chronic lymphocytic leukemia cellsDamjan Avsec, Alma Tana Jakoš Djordjevič, Maša Kandušer, Helena Podgornik, Matevž Škerget, Irena Mlinarič-Raščan, 2021, izvirni znanstveni članek Ključne besede: chronic lymphocytic leukemia, autophagy, AMPK/ULK1, venetoclax, drug resistance, targeted therapy Celotno besedilo (datoteka, 5,50 MB) Gradivo ima več datotek! Več... |
10. The enhanced cytotoxic effects in B-cell leukemia and lymphoma following activation of prostaglandin EP4 receptor and targeting of CD20 antigen by monoclonal antibodiesTijana Markovič, Helena Podgornik, Damjan Avsec, Sanja Nabergoj, Irena Mlinarič-Raščan, 2022, izvirni znanstveni članek Ključne besede: B-cell leukemia and lymphoma, chronic lymphocytic leukemia, prostaglandin EP4 receptor, selective EP4 receptor agonist, monoclonal antibodies, synergistic effects Celotno besedilo (datoteka, 1,90 MB) Gradivo ima več datotek! Več... |